Edward Trybala

2.8k total citations
63 papers, 2.2k citations indexed

About

Edward Trybala is a scholar working on Epidemiology, Immunology and Molecular Biology. According to data from OpenAlex, Edward Trybala has authored 63 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Epidemiology, 18 papers in Immunology and 17 papers in Molecular Biology. Recurrent topics in Edward Trybala's work include Herpesvirus Infections and Treatments (38 papers), Virus-based gene therapy research (11 papers) and Toxin Mechanisms and Immunotoxins (11 papers). Edward Trybala is often cited by papers focused on Herpesvirus Infections and Treatments (38 papers), Virus-based gene therapy research (11 papers) and Toxin Mechanisms and Immunotoxins (11 papers). Edward Trybala collaborates with scholars based in Sweden, Poland and United States. Edward Trybala's co-authors include Tomas Bergström, Bo Svennerholm, Jan‐Åke Liljeqvist, Vito Ferro, Sigvard Olofsson, Maria Ekblad, Maria E. Johansson, Beata Adamiak, Dorothe Spillmann and Joseph C. Glorioso and has published in prestigious journals such as Journal of Biological Chemistry, Water Research and Journal of Virology.

In The Last Decade

Edward Trybala

60 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward Trybala Sweden 26 836 813 458 413 325 63 2.2k
Debasish Chattopadhyay United States 25 573 0.7× 1.0k 1.3× 263 0.6× 182 0.4× 116 0.4× 79 1.9k
Laura J. Knoll United States 29 918 1.1× 1.2k 1.4× 225 0.5× 195 0.5× 244 0.8× 88 2.7k
Kazuya I.P.J. Hidari Japan 28 646 0.8× 1.2k 1.5× 141 0.3× 307 0.7× 508 1.6× 75 2.4k
Enrique Villar Spain 25 698 0.8× 852 1.0× 129 0.3× 278 0.7× 158 0.5× 78 1.9k
Utpal Tatu India 31 526 0.6× 1.6k 2.0× 424 0.9× 464 1.1× 354 1.1× 90 2.9k
Huarong Huang China 29 521 0.6× 1.2k 1.5× 129 0.3× 725 1.8× 712 2.2× 74 3.5k
Thaïs Souto-Padrón Brazil 35 1.9k 2.2× 1.4k 1.7× 175 0.4× 305 0.7× 465 1.4× 107 3.6k
Angelina S. Palma Portugal 24 519 0.6× 1.1k 1.4× 218 0.5× 421 1.0× 521 1.6× 55 2.4k
Valeria Cagno Switzerland 25 489 0.6× 545 0.7× 94 0.2× 524 1.3× 296 0.9× 58 1.8k
Luis M. Schang Canada 32 1.3k 1.5× 804 1.0× 101 0.2× 322 0.8× 650 2.0× 70 2.7k

Countries citing papers authored by Edward Trybala

Since Specialization
Citations

This map shows the geographic impact of Edward Trybala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Trybala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Trybala more than expected).

Fields of papers citing papers by Edward Trybala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Trybala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Trybala. The network helps show where Edward Trybala may publish in the future.

Co-authorship network of co-authors of Edward Trybala

This figure shows the co-authorship network connecting the top 25 collaborators of Edward Trybala. A scholar is included among the top collaborators of Edward Trybala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward Trybala. Edward Trybala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Omosa, Leonidah Kerubo, Andreas Orthaber, Jacob O. Midiwo, et al.. (2024). Bioactive abietenolide diterpenes from Suregada procera. Fitoterapia. 179. 106217–106217.
4.
Atilaw, Yoseph, et al.. (2021). Antiviral iridoid glycosides from Clerodendrum myricoides. Fitoterapia. 155. 105055–105055. 7 indexed citations
5.
Delguste, Martin, Edward Trybala, Sigvard Olofsson, et al.. (2019). Regulatory Mechanisms of the Mucin-Like Region on Herpes Simplex Virus during Cellular Attachment. ACS Chemical Biology. 14(3). 534–542. 20 indexed citations
6.
Block, Stephan, Stephanie Möller, Matthias Schnabelrauch, et al.. (2017). Binding Kinetics and Lateral Mobility of HSV-1 on End-Grafted Sulfated Glycosaminoglycans. Biophysical Journal. 113(6). 1223–1234. 26 indexed citations
7.
Dijkman, Ronald, Tomas Bergström, Nina Kann, et al.. (2014). Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus. PLoS Pathogens. 10(5). e1004166–e1004166. 133 indexed citations
8.
Bergström, Tomas, et al.. (2011). Potent anti-respiratory syncytial virus activity of a cholestanol-sulfated tetrasaccharide conjugate. Antiviral Research. 93(1). 101–109. 21 indexed citations
9.
Adamiak, Beata, Edward Trybala, Maria E. Johansson, et al.. (2010). Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain. Virology. 400(2). 197–206. 20 indexed citations
10.
Trybala, Edward, Sigvard Olofsson, Bo Svennerholm, et al.. (2004). Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells. Antiviral Research. 62(3). 125–134. 19 indexed citations
11.
Ekblad, Maria, Tomas Bergström, Craig Freeman, et al.. (2004). The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Research. 63(1). 15–24. 94 indexed citations
12.
Liljeqvist, Jan‐Åke, Edward Trybala, Johan Hoebeke, Bo Svennerholm, & Tomas Bergström. (2002). Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. Journal of General Virology. 83(1). 157–165. 24 indexed citations
13.
Trybala, Edward, et al.. (2001). Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C. Journal of General Virology. 82(8). 1941–1950. 57 indexed citations
14.
Trybala, Edward, Jan‐Åke Liljeqvist, Bo Svennerholm, & Tomas Bergström. (2000). Herpes Simplex Virus Types 1 and 2 Differ in Their Interaction with Heparan Sulfate. Journal of Virology. 74(19). 9106–9114. 113 indexed citations
15.
Olofsson, Sigvard, Anders Bolmstedt, Johan Leckner, et al.. (1999). The role of a single N-linked glycosylation site for a functional epitope of herpes simplex virus type 1 envelope glycoprotein gC. Glycobiology. 9(1). 73–81. 16 indexed citations
16.
Trybala, Edward, Tomas Bergström, Dorothe Spillmann, et al.. (1998). Interaction between Pseudorabies Virus and Heparin/Heparan Sulfate. Journal of Biological Chemistry. 273(9). 5047–5052. 42 indexed citations
17.
Trybala, Edward, Tomas Bergström, Dorothe Spillmann, et al.. (1996). Mode of Interaction between Pseudorabies Virus and Heparan Sulfate/Heparin. Virology. 218(1). 35–42. 23 indexed citations
18.
Trybala, Edward, Tomas Bergström, Bo Svennerholm, et al.. (1994). Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate. Journal of General Virology. 75(4). 743–752. 93 indexed citations
19.
Trybala, Edward, et al.. (1993). An Evaluation of an Intradermal Test for the Diagnosis of Bovine Herpesvirus Type 1 (BHV‐1) Infection in Cattle. Journal of Veterinary Medicine Series B. 40(1-10). 21–26. 1 indexed citations
20.
Trybala, Edward, et al.. (1990). Hemagglutination by herpes simplex virus type 1. Archives of Virology. 113(1-2). 89–94. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026